The plantar fascia is an inelastic, broad band of tissue on the plantar or undersurface of
the foot.
Plantar fasciitis is an inflammation of the plantar fascia that causes heel and foot pain.
The current standard orthopaedic management of plantar fasciitis begins with nonsurgical
treatment modalities. Surgical treatment of plantar fasciitis is indicated only if
nonsurgical means fail.
A newer method of treating plantar fasciitis before resorting to surgery is the use of
Botulinum Toxin or Xeomin (incobotulinum toxin A, Merz USA). Treatment of plantar fasciitis
with Xeomin is important, as there are limited studies on the subject to date. The purpose of
this study is to examine the long-term results of using Xeomin to treat plantar fasciitis in
one physician's (J.A.) practice at Rothman Institute Orthopaedics through a
placebo-controlled, randomized, double-blinded study.
Phase:
Phase 4
Details
Lead Sponsor:
Rothman Institute Orthopaedics
Collaborators:
Merz North America, Inc. Merz Pharmaceuticals, LLC